A combination chemotherapy of 5-fluorouracil (5-FU) and cisplatin (CDDP) has demonstrated activities in various malignancies, including head and neck, lung, esophageal, gastric, and pancreatic cancers. We reviewed our experience of 11 patients diagnosed as carcinoma of unknown primary site (CUPS), who were treated with infusional 5-FU and CDDP between January 1998 and December 2005. The median number of cycles administered was three (range: 1-12). All patients had measurable disease. Six partial responses were obtained (response rate: 54.5%, 95% confidence interval: 23.4-83.3%). The median survival time for all patients was 10 mo (range, 2-37 mo). The median time to disease progression was 3 mo (range, 1-6 mo). This regimen was well tolerated, with grade 3-4 neutropenia (two patients), febrile neutropenia (one patient), grade 3 nausea/vomiting (one patient), and grade 3 stomatitis (two patients). Grade 2 leukoencephalopathy was observed in one patient. No treatment-related death was observed. The combination chemotherapy of infusional 5-FU and CDDP was feasible and tolerated with promising activity for CUPS.
Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site. Publishing Authors By Initials
Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site. Journal Published:
PUBLICATION TYPE: Journal Article
Journal: Medical oncology (Northwood, London, England)
VOLUME: 24
Page Numbers: 259-64
Journal Abbreviation: Med. Oncol.
ISSN: 1357-0560
DAY: 12
MONTH: 09
YEAR: 2007
Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 9435512
Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site.
AFFILIATION: First Department of Medicine and Department of Bio systemic Science of Medicine, Kyushu University Graduate School of Medicine, Fukuoka, Japan. hkusaba@intmed1.med.kyushu-u.ac.jp
Country: United States
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Med Oncol
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site Related Publications